Announcement:

Join us for our next LinkedIn Live Event on Thursday 26th June 2025, where Dr Maria Georgiou PhD, will present on "In Vitro Retinal Models: A New Era in Drug Discovery & Gene Therapy"

Find out more

Home › Resources › Posters › High content imaging (HCI) assays enable the study of the fibrotic processes: fibroblast – to – myofibroblast transition (FMT) and epithelial – to – mesenchymal transition (EMT)

High content imaging (HCI) assays enable the study of the fibrotic processes: fibroblast – to – myofibroblast transition (FMT) and epithelial – to – mesenchymal transition (EMT)

Discover about how excessive and abnormal deposition of extracellular matrix (ECM) is a characteristic feature of fibrotic lung disease, such as idiopathic pulmonary fibrosis (IPF).
Learn about how repetitive injury to lower airway epithelial cells drives epithelial-to-mesenchymal transition (EMT).
In this study, we model FMT and EMT process in-vitro using high content imaging (HCI) enables compound screening to assist anti-fibrotic drug discovery.

Published

17th June, 2024

Published by

Fiona Leslie, Oliver Birch, Chloe Whiting, Megan Webster

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View this resource

Please click the button below to download this resource.

Download Now

Book a Call